Remedium Capital Partners, LLC Long-Term Concentrated

Location: Fort Lauderdale, FL

CIK: 0002104501 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 7, 2026

Total Value: $452M (100.0% shares, 0.0% debt)

Holdings (6)

New Positions (1)

CBIO Crescent Biopharma Inc 1.4%

Value $6.503M Shares 361,250 Est. Cost $18.00 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
CBIO	Crescent Biopharma Inc	361,250	$6.503M	1.4%	$18.00	—	COM	G2545C104

Exited Positions (1)

— Crescent Biopharma Inc 1.5%

Value $6.636M Shares 361,250 Est. Cost $11.86 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Crescent Biopharma Inc	361,250	$6.636M	1.5%	$11.86	—	—	38000Q201

Unchanged Positions (5)

ORKA Oruka Therapeutics Inc 33.0%

Value $149M Shares 1,565,661 Est. Cost $27.86 Unrealized —

SYRE Spyre Therapeutics Inc 28.8%

Value $130M Shares 1,464,169 Est. Cost $26.13 Unrealized —

APGE Apogee Therapeutics Inc 17.2%

Value $77.87M Shares 586,691 Est. Cost $62.99 Unrealized —

JBIO Jade Biosciences Inc 7.8%

Value $35.06M Shares 1,577,750 Est. Cost $11.73 Unrealized —

GLTO Damora Therapeutics Inc 11.8%

Value $53.2M Shares 2,045,473 Est. Cost $25.31 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ORKA	Oruka Therapeutics Inc	1,565,661	$149M	33.0%	$27.86	—	COM	687604108
SYRE	Spyre Therapeutics Inc	1,464,169	$130M	28.8%	$26.13	—	COM	00773J202
APGE	Apogee Therapeutics Inc	586,691	$77.87M	17.2%	$62.99	—	COM	03770N101
JBIO	Jade Biosciences Inc	1,577,750	$35.06M	7.8%	$11.73	—	COM	008064206
GLTO	Damora Therapeutics Inc	2,045,473	$53.2M	11.8%	$25.31	—	COM	36322Q206